Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lanza

Showing results (351-360 of 365) with videos related to

Pageof 37
Sort By:
Plos One|July 25, 2009
Assessment of local public health workers' willingness to respond to pandemic influenza through application of the extended parallel process modelDaniel J Barnett, Ran D Balicer, Carol B Thompson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 30, 2010
MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma modelKent S Boles, Anne H Schmieder, Alexander W Koch, et al.
Theranostics|January 3, 2017
Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway RatGregory M Lanza, John Jenkins, Anne H Schmieder, et al.
Theranostics|July 21, 2020
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast CancerAlison K Esser, Michael H Ross, Francesca Fontana, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|December 17, 2013
Assessing the barriers to image-guided drug deliveryGregory M Lanza, Chrit Moonen, James R Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong SurvivalFrancesca Fontana, Michael J Scott, John S Allen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2014
Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac functionKristin P Bibee, Ya-Jian Cheng, James K Ching, et al.
Plos One|December 20, 2023
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targetingFrancesca Fontana, Alison K Esser, Christopher Egbulefu, et al.
Journal of Bone Oncology|May 7, 2026
CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapyXinming Su, Takayuki Kobayashi, Jingyu Xiang, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 20, 2024
Correction to "Anisotropic Superconducting Nb<sub>2</sub>CT<sub>x</sub> MXene Processed by Atomic Exchange at the Wafer Scale"X Xu, C Zhang, J Yin, et al.
Pageof 37

Showing results (351-360 of 365) with videos related to

Sort By:
Pageof 37
Plos One|July 25, 2009
Assessment of local public health workers' willingness to respond to pandemic influenza through application of the extended parallel process modelDaniel J Barnett, Ran D Balicer, Carol B Thompson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 30, 2010
MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma modelKent S Boles, Anne H Schmieder, Alexander W Koch, et al.
Theranostics|January 3, 2017
Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway RatGregory M Lanza, John Jenkins, Anne H Schmieder, et al.
Theranostics|July 21, 2020
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast CancerAlison K Esser, Michael H Ross, Francesca Fontana, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|December 17, 2013
Assessing the barriers to image-guided drug deliveryGregory M Lanza, Chrit Moonen, James R Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong SurvivalFrancesca Fontana, Michael J Scott, John S Allen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2014
Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac functionKristin P Bibee, Ya-Jian Cheng, James K Ching, et al.
Plos One|December 20, 2023
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targetingFrancesca Fontana, Alison K Esser, Christopher Egbulefu, et al.
Journal of Bone Oncology|May 7, 2026
CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapyXinming Su, Takayuki Kobayashi, Jingyu Xiang, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 20, 2024
Correction to "Anisotropic Superconducting Nb<sub>2</sub>CT<sub>x</sub> MXene Processed by Atomic Exchange at the Wafer Scale"X Xu, C Zhang, J Yin, et al.
Pageof 37